Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mudaliar

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Diabetes, Obesity & Metabolism|April 5, 2013
Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trialG A Bray, S R Smith, M A Banerji, et al.
Diabetes, Obesity & Metabolism|October 11, 2016
Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetesS Mudaliar, R R Henry, T P Ciaraldi, et al.
JAMA Oncology|February 28, 2020
Global Retinoblastoma Presentation and Analysis by National Income Level, Ido Didi Fabian, Elhassan Abdallah, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Diabetes, Obesity & Metabolism|April 5, 2013
Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trialG A Bray, S R Smith, M A Banerji, et al.
Diabetes, Obesity & Metabolism|October 11, 2016
Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetesS Mudaliar, R R Henry, T P Ciaraldi, et al.
JAMA Oncology|February 28, 2020
Global Retinoblastoma Presentation and Analysis by National Income Level, Ido Didi Fabian, Elhassan Abdallah, et al.
Pageof 5